Parenteral delivery device and methods of use
A parenteral delivery device and method of delivering a multi-system treatment to a centralized location where the delivery device includes at least an inner compartment encapsulating a first system and an outer compartment encapsulating a second system and the first and second systems have different mechanisms of action for use in the treatment of vaginal infection.
1. A delivery device, comprising:
a first compartment comprising a synbiotic, wherein the synbiotic comprises about 75 mg to about 125 mg by weight of a dry prebiotic and about 100 mg to about 450 mg by weight of a dry probiotic, wherein the dry probiotic comprises Lactobacillus Iners, Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus jensenii , or combinations thereof;
a second compartment comprising a slurry, wherein the slurry consists of about 50 mg to about 600 mg hydrogen borate and about 150 mg to about 580 mg of an oil medium, and wherein the second compartment is disposed about the first compartment.
2. The delivery device of claim 1 , wherein the prebiotic comprises a bifidogenic oligosaccharide selected from the group consisting of fructo-oligosaccharide, galacto-oligosaccharide, inulin, isomalto-oligosaccharide, lactulose, soy-oligosaccharide, xylo-oligosaccharide, and combinations thereof.
3. The delivery device of claim 1 , wherein the device is in the form of a suppository.
4. The delivery device of claim 1 , wherein the dry prebiotic and the dry probiotic are each in the form of a powder.
5. The delivery device of claim 1 , wherein the first compartment has a first diameter and the second compartment has a second diameter, and wherein the first diameter is between about 55 percent to about 80 percent of the second diameter.
6. The delivery device of claim 1 , wherein the first compartment has a first length and the second compartment has a second length, and wherein the first length is at between about 15 percent and 40 percent of the second length.
7. The delivery device of claim 1 , wherein the first compartment and the second compartment are each in the form of a capsule.
8. The vaginal delivery device of claim 1 , wherein the oil medium is coconut oil.
9. The vaginal delivery device of claim 1 , wherein the hydrogen borate is present in the slurry in an amount of about 250 mg to about 400 mg.
10. A vaginal delivery device comprising:
a first capsule having a first dissolution rate and enclosing a slurry, wherein the slurry consists of about 200 mg to about 500 mg hydrogen borate and about 150 mg to about 580 mg coconut oil,
a second capsule having a second dissolution rate and comprising a synbiotic powder, wherein the synbiotic powder comprises about 75 mg to about 125 mg by weight of a dry prebiotic powder and about 100 mg to about 450 mg by weight of a dry probiotic powder, wherein the dry probiotic powder comprises Lactobacillus Iners, Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus jensenii , or combinations thereof,
wherein the first capsule is disposed about the second capsule, and
wherein the first dissolution rate is greater than the second dissolution rate.
11. The vaginal delivery device of claim 10 , wherein the first dissolution rate is between about 2 minutes and 15 minutes and the second dissolution rate is between about 30 minutes and about 90 minutes.
12. The vaginal delivery device of claim 10 , wherein the dry prebiotic powder comprises a short chain fructo-oligosaccharide.
13. The vaginal delivery device of claim 10 , wherein the synbiotic powder further comprises a preservative.
14. The vaginal delivery device of claim 10 , wherein the first capsule has a first length and the second capsule has a second length, and wherein the second length is about 10 percent to about 40 percent less than the first length.
15. A vaginal delivery device comprising:
a first capsule enclosing a slurry, wherein the slurry consists of hydrogen borate and an oil medium, wherein the oil medium is present in the slurry in an amount of about 150 mg to about 580 mg,
a second capsule comprising a synbiotic, wherein the synbiotic comprises about 80 mg to about 140 mg by weight of a dry prebiotic powder and about 75 mg to about 400 mg by weight of a dry probiotic powder, wherein the dry prebiotic powder comprises a short chain fructo-oligosaccharide, and wherein the dry probiotic powder comprises Lactobacillus Iners, Lactobacillus crispatus, Lactobacillus gasseri , and Lactobacillus jensenii , and
wherein the first capsule is disposed about the second capsule.
16. The vaginal delivery device of claim 15 , wherein the oil medium is coconut oil.
17. The vaginal delivery device of claim 15 , wherein the first capsule has a first dissolution rate and the second capsule has a second dissolution rate, wherein the first dissolution rate is greater than the second dissolution rate.
18. The vaginal delivery device of claim 15 , wherein the synbiotic further comprises a preservative.